-+ 0.00%
-+ 0.00%
-+ 0.00%

Barinthus Biotherapeutics Q2 EPS $(0.26) Beats $(0.30) Estimate

Benzinga·08/06/2026 12:42:18
Listen to the news
Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 50 percent increase over losses of $(0.52) per share from the same period last year.